Review: Conjunctival haemorrhage in Gleevec
This is a review of Conjunctival haemorrhage by studying 19,837 people who take Gleevec. We analyze: the time on Gleevec when people have Conjunctival haemorrhage, gender and age of these people, the severity of Conjunctival haemorrhage, how they recovered, and common conditions and drugs used besides Gleevec. The review is created by eHealthMe based on reports from FDA and social media, and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 200 million drug outcomes from FDA and social media since 1977. The results are personalized to your gender and age. Start now >>>
Gleevec (latest outcomes) has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml), chronic myeloid leukaemia. Commonly reported side effects of Gleevec include nausea aggravated, nausea, fever, rashes, diarrhea.
Conjunctival haemorrhage (is bleeding underneath the conjunctiva) has been reported by people with onchocerciasis, osteoporosis, multiple myeloma, high blood pressure, depression.
On Dec, 2, 2013: 19,837 people reported to have side effects when taking Gleevec. Among them, 83 people (0.42%) have Conjunctival Haemorrhage.
Time on Gleevec when people have Conjunctival haemorrhage * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Conjunctival haemorrhage||20.59%||35.29%||23.53%||0.00%||5.88%||14.71%||0.00% |
Gender of people who have Conjunctival haemorrhage when taking Gleevec * :
|Conjunctival haemorrhage||75.22%||24.78% |
Age of people who have Conjunctival haemorrhage when taking Gleevec * :
|Conjunctival haemorrhage||0.00%||0.00%||0.00%||0.00%||8.99%||15.73%||11.24%||64.04% |
Severity of Conjunctival haemorrhage when taking Gleevec ** :
How people recovered from Conjunctival haemorrhage ** :
Top conditions involved for these people * :
- Chronic myeloid leukaemia (53 people, 63.86%)
- Gastrointestinal stromal tumour (14 people, 16.87%)
- Hypothyroidism (8 people, 9.64%)
- Nausea (6 people, 7.23%)
- Chronic myeloid leukaemia (in remission) (6 people, 7.23%)
Top co-used drugs for these people * :
- Vitamin d (11 people, 13.25%)
- Folic acid (10 people, 12.05%)
- Ambien (9 people, 10.84%)
- Lasix (8 people, 9.64%)
- Atenolol (8 people, 9.64%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related search: Gleevec, Conjunctival haemorrhage
You can also:
On eHealthMe, Gleevec (imatinib mesylate) is often used for chronic myelogenous leukemia (cml). Find out below the conditions Gleevec is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Gleevec used for and how effective is it:
Other drugs that are used to treat the same conditions:
Browse Gleevec side effects from A to Z:
Browse Gleevec drug interactions with drugs from A to Z:
Drugs in real world that are associated with:
Could your condition cause it?
Can you answer these questions (what is this?):
More questions for: Gleevec, Conjunctival haemorrhage
More reviews for: Gleevec, Conjunctival haemorrhage
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.